QCM
IDXX icon

QRG Capital Management’s Idexx Laboratories IDXX Stock Holding History

QRG Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
3,323
+477
+17% +$268K 0.01% 492
2026
Q1 		$1.6M Buy
2,846
+350
+14% +$224K 0.02% 463
2025
Q4 		$1.69M Buy
2,496
+566
+29% +$385K 0.02% 440
2025
Q3 		$1.23M Buy
1,930
+369
+24% +$224K 0.01% 480
2025
Q2 		$837K Sell
1,561
-498
-24% -$238K 0.01% 649
2025
Q1 		$865K Sell
2,059
-29
-1% -$12.6K 0.01% 616
2024
Q4 		$863K Sell
2,088
-19
-0.9% -$8.33K 0.01% 617
2024
Q3 		$1.06M Buy
2,107
+96
+5% +$46.6K 0.01% 576
2024
Q2 		$980K Sell
2,011
-1,714
-46% -$860K 0.01% 552
2024
Q1 		$2.01M Buy
3,725
+258
+7% +$141K 0.03% 419
2023
Q4 		$1.92M Buy
3,467
+245
+8% +$115K 0.03% 404
2023
Q3 		$1.41M Buy
+3,222
New +$1.61M 0.02% 434

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

QRG Capital Management's IDXX Position: Q2 2026 in Review

QRG Capital Management increased its Idexx Laboratories (IDXX) stake by 17% in Q2 2026, buying an estimated $268K and bringing the position to 3,323 shares worth $1.75M. The position accounts for 0.01% of the portfolio, ranked #492.

QRG Capital Management first reported a position in IDXX in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.01M in Q1 2024. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • QRG Capital Management held 3,323 shares of Idexx Laboratories worth $1.75M as of Q2 2026.
  • QRG Capital Management bought 477 Idexx Laboratories shares in Q2 2026, an estimated $268K.
  • Idexx Laboratories made up 0.01% of QRG Capital Management's portfolio in Q2 2026, its #492 holding.
  • QRG Capital Management first reported a position in Idexx Laboratories in Q3 2023 and has held it in 12 quarters since.
  • QRG Capital Management's Idexx Laboratories position peaked at $2.01M in Q1 2024.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.